
Dutch-based US pharmaceutical giant Mylan's independent foundation said Thursday it will excercise a call option allowing it buy shares to control half the company in fending off a hostile takeover bid by Israeli rival Teva.
The foundation "formed its independent judgement that Mylan's best interests are at risk as a consequence of the uncertainty and threats associated by a possible takeover by Teva," Mylan said in a statement.
Mylan, a US company that moved to the Netherlands a year ago for fiscal reasons, had dismissed Teva's earlier bid in April.
GMT 14:12 2018 Tuesday ,23 January
Oscar best director nomineesGMT 14:09 2018 Tuesday ,23 January
Oscar best actress nomineesGMT 14:06 2018 Tuesday ,23 January
Oscar best actor nomineesGMT 13:58 2018 Tuesday ,23 January
Oscar best foreign film nomineesGMT 20:03 2018 Monday ,22 January
Eurozone approves 6.7-bln-euro bailout tranche for GreeceGMT 20:00 2018 Monday ,22 January
Trump to travel to Davos as shutdown deal reached: W.HouseGMT 19:57 2018 Monday ,22 January
Democrats to vote to reopen US government: SchumerGMT 19:53 2018 Monday ,22 January
Afrin clashes kill 54 Syrian Kurd and pro-Turkey fighters: monitor
Maintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2025 ©
Maintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2025 ©
Send your comments
Your comment as a visitor